These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4709465)

  • 1. [A trial of ambulatory treatment of lung cancer by multiple chemotherapy].
    Charbonneau R; Krieger M; Bernier J
    Union Med Can; 1973 Feb; 102(2):324-9. PubMed ID: 4709465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with ambulatory intermittent cytostatic treatment of bronchial cancer].
    Macholda F; Bohut V; Votava V; Pavlova P; Mericka O; Sajnerova B
    Bronches; 1971; 21(2):197-201. PubMed ID: 4108245
    [No Abstract]   [Full Text] [Related]  

  • 3. Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia.
    Rapp JS; Perry MC; Rotche RM
    Semin Oncol; 1996 Apr; 23(2):xv-xxii; discussion xxii. PubMed ID: 8623054
    [No Abstract]   [Full Text] [Related]  

  • 4. [The action of phytohemagglutinin in the prevention and treatment of hematologic side effects of chemotherapy in broncho-pleural-pulmonary cancer].
    Brocard H; Akoun G
    Bull Mem Soc Med Hop Paris; 1967 Jan; 118(2):157-77. PubMed ID: 6061579
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of treatment of small cell carcinoma of the lung.
    Abeloff MD; Klastersky J; Drings PD; Eagan RT; Greco FA; Holsti L; Mattson K; Postmus PE
    Cancer Treat Rep; 1983 Jan; 67(1):21-6. PubMed ID: 6311410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical study of N-nitrosomethylurea].
    Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
    Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study.
    Natale RB
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):34-7. PubMed ID: 8643968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of preparations increasing the antiblastic action of antitumor substances on the results of postoperative chemotherapy in lung cancer].
    Mantsurov NE
    Vrach Delo; 1982 Apr; (4):88-91. PubMed ID: 6285619
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
    Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
    Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
    Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
    Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS; Mackel C; Pocelinko R; Salmon SE
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy versus best supportive care in the management of lung cancer.
    Shajeem O; Behera D; Aggarwal AN
    J Assoc Physicians India; 2003 Mar; 51():261-4. PubMed ID: 12839347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trial of combined radiotherapy and chemotherapy (CBDCA) for post-operative non-small cell lung cancer (N2)].
    Nakano N; Kishima H; Yamamura N; Ueda S; Kameda Y; Miyagawa M
    Gan To Kagaku Ryoho; 1999 May; 26(6):845-7. PubMed ID: 10410157
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of chemotherapy treatment on hemostasis of patients with lung cancer].
    Vorob'eva EO; Akhvlediani M; Emukhvari MG; Sharashidze NA; Gzirishvili LM
    Georgian Med News; 2008 Sep; (162):40-6. PubMed ID: 18830029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of advanced lung cancer: presentation of personal results].
    Kolarić K; Roth A; Vukas D
    Plucne Bolesti Tuberk; 1975; 27(4):247-52. PubMed ID: 1228798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.